Review article: guide to tofacitinib dosing in patients with ulcerative colitis.
Journal Information
Full Title: Aliment Pharmacol Ther
Abbreviation: Aliment Pharmacol Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of personal interest : Peter M. Irving has received grants and personal fees from Janssen, MSD and Takeda, and personal fees from AbbVie, Arena Pharmaceuticals, Dr. Falk Pharma GmbH, Eli Lilly, Ferring Pharmaceuticals, Genentech, Hospira, Pfizer Inc, Pharmacosmos, Samsung Bioepis, Sandoz, Shire, Tillotts Pharma, TopiVert, VHsquared, Vifor Pharma and Warner Chilcott. Yvette Leung has served as a consultant for AbbVie, Amgen, Janssen, Merck, Pfizer Inc and Takeda. Marla C. Dubinsky has served as a consultant for AbbVie, Arena, Bristol‐Myers Squibb, Celgene, Eli Lilly, Galapagos, Gilead, Janssen, Pfizer Inc, Prometheus Labs, Takeda, and UCB and is a shareholder of Trellus Health."
"FUNDING INFORMATION This article was funded by Pfizer. Funding for medical writing support was provided by Pfizer Inc."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025